Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Children's Oncology Group
N.N. Petrov National Medical Research Center of Oncology
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Novartis